2177 Redefining Radiotherapy for Vestibular Schwannomas: A Meta-Analysis of LINAC-Based SRS, FSRT, and HfSRT on Hearing and Cranial Nerve Outcomes

View at publisher Summarise with VIRAT
Authors: Alan M Solís Velázquez, María Fernanda F. Gutiérrez Aguilera, Diana Laura Ochoa Hernandez, Andrea Iturralde Carrillo, Andrea C. Beltrán De la Fuente, Martha Isabel Vilca-Salas
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

INTRODUCTION: Vestibular schwannomas carry a significant risk of hearing loss and cranial nerve dysfunction. Stereotactic radiotherapy, including LINAC-based stereotactic radiosurgery (SRS) and fractionated stereotactic radiotherapy (FSRT), is a standard treatment. Hypofractionated SRT (hfSRT) has emerged as a potential alternative, but the optimal fractionation strategy remains debated, particularly in relation to hearing preservation and nerve toxicity. METHODS: Following PRISMA guidelines, a systematic search of PubMed, Embase, and Cochrane Library was conducted up to March 2025. Eligible studies evaluated patients with vestibular schwannomas treated exclusively with LINAC-based SRS, FSRT, or hfSRT, and reported outcomes such as hearing preservation, postoperative disequilibrium, trigeminal nerve neuropathy, and facial nerve neuropathy. RESULTS: After screening 516 articles, eight studies comprising 1,048 patients treated exclusively with LINAC-based systems were included. No significant differences were observed between SRS and FSRT in hearing preservation (RR = 1.08; 95% CI = [0.80, 1.45]; p = 0.63), postoperative disequilibrium (RR = 1.82; 95% CI = [0.43, 7.67]; p = 0.42), or trigeminal neuropathy (RR = 2.30; 95% CI = [0.87, 6.07]; p = 0.09). However, SRS was significantly associated with higher rates of facial nerve neuropathy (RR = 7.02; 95% CI = [2.90, 17.03]; p < 0.0001). In a subgroup analysis comparing SRS versus hypofractionated SRT, hearing preservation favored hfSRT without reaching statistical significance (RR = 0.79; 95% CI = [0.56, 1.10]; p = 0.16). CONCLUSIONS: SRS and FSRT demonstrated similar outcomes in hearing preservation, disequilibrium, and trigeminal neuropathy. However, SRS was linked to increased facial nerve toxicity. Hearing outcomes favored hfSRT, highlighting its potential as an effective alternative. Further high-quality, prospective studies are needed to guide optimal radiotherapy strategies for vestibular schwannomas.

Fields of Study & Subjects

Meningioma and schwannoma management Pituitary Gland Disorders and Treatments Trigeminal Neuralgia and Treatments

Publication details

Journal / source
Neurosurgery
Volume
72
Issue
Supplement_1
Pages
295–295
Publication date
26 March 2026
Language
EN